Dana Holger

845 total citations · 1 hit paper
27 papers, 538 citations indexed

About

Dana Holger is a scholar working on Molecular Medicine, Infectious Diseases and Ecology. According to data from OpenAlex, Dana Holger has authored 27 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Medicine, 11 papers in Infectious Diseases and 9 papers in Ecology. Recurrent topics in Dana Holger's work include Antibiotic Resistance in Bacteria (14 papers), Bacteriophages and microbial interactions (9 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Dana Holger is often cited by papers focused on Antibiotic Resistance in Bacteria (14 papers), Bacteriophages and microbial interactions (9 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Dana Holger collaborates with scholars based in United States and Saudi Arabia. Dana Holger's co-authors include Ashlan J. Kunz Coyne, Amer El Ghali, Nicholas Rebold, Michael J. Rybak, Michael J. Rybak, Taylor Morrisette, Razieh Kebriaei, Travis J. A. Craddock, Katherine L. Lev and Jaime L. Tartar and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Journal of Applied Microbiology.

In The Last Decade

Dana Holger

24 papers receiving 520 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa

2022 162 citations Ashlan J. Kunz Coyne, Amer El Ghali et al. Infectious Diseases and Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dana Holger United States	13	224	158	157	99	96	27	538
Bahman Mirzaei Iran	15	218 1.0×	47 0.3×	331 2.1×	71 0.7×	48 0.5×	61	669
Matthew D. Johnson United States	16	225 1.0×	94 0.6×	309 2.0×	15 0.2×	37 0.4×	31	737
Yonas A. Alamneh United States	17	164 0.7×	36 0.2×	214 1.4×	19 0.2×	84 0.9×	30	658
Farah Al‐Marzooq United Arab Emirates	17	187 0.8×	21 0.1×	206 1.3×	38 0.4×	30 0.3×	49	669
Κωνσταντίνα Κοντοπούλου Greece	10	258 1.2×	35 0.2×	54 0.3×	86 0.9×	12 0.1×	20	506
Véronique Dupouy France	12	193 0.9×	26 0.2×	138 0.9×	16 0.2×	32 0.3×	25	500
Renchi Fang China	15	268 1.2×	26 0.2×	414 2.6×	32 0.3×	27 0.3×	20	869
Roberto Fontana Italy	10	170 0.8×	52 0.3×	139 0.9×	47 0.5×	10 0.1×	22	343
Thea Brennan-Krohn United States	14	185 0.8×	10 0.1×	74 0.5×	49 0.5×	22 0.2×	21	416
Betina Orman Argentina	14	282 1.3×	45 0.3×	197 1.3×	23 0.2×	8 0.1×	42	744

Countries citing papers authored by Dana Holger

Since Specialization

Citations

This map shows the geographic impact of Dana Holger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Holger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Holger more than expected).

Fields of papers citing papers by Dana Holger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Holger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Holger. The network helps show where Dana Holger may publish in the future.

Co-authorship network of co-authors of Dana Holger

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Holger. A scholar is included among the top collaborators of Dana Holger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Holger. Dana Holger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pham, Huy P., et al.. (2024). Antibiotic-induced neuropsychiatric toxicity: epidemiology, mechanisms and management strategies –a narrative literature review. Drugs in Context. 13. 1–18. 7 indexed citations

Holger, Dana, et al.. (2024). Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 44(3). 268–282. 3 indexed citations

Coyne, Ashlan J. Kunz, et al.. (2024). Penicillin allergy reassessment for treatment improvement. The Journal of the American Dental Association. 155(5). 379–389.

Hale, Genevieve M, et al.. (2024). Assessing Confidence and Competence of Student Pharmacists in a Virtual Medication Adherence Training Program. American Journal of Pharmaceutical Education. 88(5). 100699–100699.

Coyne, Ashlan J. Kunz, Amer El Ghali, Nicholas Rebold, et al.. (2023). High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production. Open Forum Infectious Diseases. 10(3). ofad034–ofad034. 15 indexed citations

Morrisette, Taylor, Kyle Stamper, Katherine L. Lev, et al.. (2023). Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model. Antimicrobial Agents and Chemotherapy. 67(6). e0131722–e0131722. 4 indexed citations

Rebold, Nicholas, Abdalhamid M Lagnf, Sara Alosaimy, et al.. (2023). Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology Spectrum. 11(1). e0264722–e0264722. 14 indexed citations

Holger, Dana, Nicholas Rebold, Sara Alosaimy, et al.. (2022). Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections. Infectious Diseases and Therapy. 11(5). 1965–1980. 10 indexed citations

Holger, Dana, et al.. (2022). Post‐graduate pharmacy fellowships: The current state of affairs. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6(2). 145–153. 1 indexed citations

10.

Rebold, Nicholas, Sara Alosaimy, Taylor Morrisette, et al.. (2022). Clinical Characteristics Associated with Bacterial Bloodstream Coinfection in COVID-19. Infectious Diseases and Therapy. 11(3). 1281–1296. 5 indexed citations

11.

Kebriaei, Razieh, Katherine L. Lev, Kyle Stamper, et al.. (2022). Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro : Bacteriophage-Antibiotic Combination. Microbiology Spectrum. 10(2). e0041122–e0041122. 31 indexed citations

12.

Lev, Katherine L., Ashlan J. Kunz Coyne, Razieh Kebriaei, et al.. (2022). Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR Enterococcus faecium. Antibiotics. 11(3). 392–392. 18 indexed citations

13.

Coyne, Ashlan J. Kunz, Amer El Ghali, Dana Holger, Nicholas Rebold, & Michael J. Rybak. (2022). Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa. Infectious Diseases and Therapy. 11(2). 661–682. 162 indexed citations breakdown →

14.

Ghali, Amer El, Taylor Morrisette, Kyle C. Molina, et al.. (2022). 1422. A Multi-Center Evaluation of Omadacycline for Multi-Drug Resistant Infections. Open Forum Infectious Diseases. 9(Supplement_2). 1 indexed citations

15.

Holger, Dana, Katherine L. Lev, Razieh Kebriaei, et al.. (2022). Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing. Journal of Applied Microbiology. 133(3). 1636–1649. 30 indexed citations

16.

Coyne, Ashlan J. Kunz, Kyle Stamper, Razieh Kebriaei, et al.. (2022). Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant Enterococcus faecium with Preserved Phage Susceptibility. Antibiotics. 11(9). 1175–1175. 21 indexed citations

17.

Rebold, Nicholas, Taylor Morrisette, Abdalhamid M Lagnf, et al.. (2021). Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections. Open Forum Infectious Diseases. 8(12). ofab554–ofab554. 24 indexed citations

18.

Rebold, Nicholas, Dana Holger, Sara Alosaimy, Taylor Morrisette, & Michael J. Rybak. (2021). COVID-19: Before the Fall, An Evidence-Based Narrative Review of Treatment Options. Infectious Diseases and Therapy. 10(1). 93–113. 9 indexed citations

19.

Holger, Dana, Katherine L. Lev, Razieh Kebriaei, et al.. (2021). 132. Evaluation Phage Cocktails in Combination with Ciprofloxacin Against Multidrug-Resistant Pseudomonas aeruginosa Overexpressing MexAB-OprM Efflux Systems. Open Forum Infectious Diseases. 8(Supplement_1). S81–S81.

20.

Trivedi, Malav, et al.. (2017). Short-term sleep deprivation leads to decreased systemic redox metabolites and altered epigenetic status. PLoS ONE. 12(7). e0181978–e0181978. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact